NEW YORK (GenomeWeb) — DNA testing firm PathogenDx announced today that it has closed a $3.4 million convertible note round.

The round was co-led by Altitude Investment Management and the Panther Opportunity Fund, with participation from CanopyVentures, Tendaji Investments, PB Venture Group, Salveo Capital, Halley Valley Venture, FlatIron Group, and Spearflower VC. Specific terms of the round were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Sponsored by
Twist Bioscience

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.

Sponsored by

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.